Your browser doesn't support javascript.
loading
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
Frampton, Adam E; Castellano, Leandro; Colombo, Teresa; Giovannetti, Elisa; Krell, Jonathan; Jacob, Jimmy; Pellegrino, Loredana; Roca-Alonso, Laura; Funel, Niccola; Gall, Tamara M H; De Giorgio, Alexander; Pinho, Filipa G; Fulci, Valerio; Britton, David J; Ahmad, Raida; Habib, Nagy A; Coombes, R Charles; Harding, Victoria; Knösel, Thomas; Stebbing, Justin; Jiao, Long R.
Afiliação
  • Frampton AE; HPB Surgical Unit, Department of Surgery and Cancer, Imperial College, London, UK.
  • Castellano L; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK. Electronic address: l.castellano@imperial.ac.uk.
  • Colombo T; Department of Cellular Biotechnology and Haematology, La Sapienza University, Rome, Italy.
  • Giovannetti E; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
  • Krell J; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Jacob J; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Pellegrino L; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Roca-Alonso L; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Funel N; Experimental and Molecular Oncology, Department of Surgery, University of Pisa, Pisa, Italy.
  • Gall TM; HPB Surgical Unit, Department of Surgery and Cancer, Imperial College, London, UK.
  • De Giorgio A; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Pinho FG; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Fulci V; Department of Cellular Biotechnology and Haematology, La Sapienza University, Rome, Italy.
  • Britton DJ; Proteome Sciences plc, King's College, London, UK.
  • Ahmad R; Department of Pathology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
  • Habib NA; HPB Surgical Unit, Department of Surgery and Cancer, Imperial College, London, UK.
  • Coombes RC; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Harding V; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Knösel T; Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany.
  • Stebbing J; Division of Oncology, Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College, Hammersmith Hospital, London, UK.
  • Jiao LR; HPB Surgical Unit, Department of Surgery and Cancer, Imperial College, London, UK. Electronic address: l.jiao@imperial.ac.uk.
Gastroenterology ; 146(1): 268-77.e18, 2014 Jan.
Article em En | MEDLINE | ID: mdl-24120476
BACKGROUND & AIMS: There has not been a broad analysis of the combined effects of altered activities of microRNAs (miRNAs) in pancreatic ductal adenocarcinoma (PDAC) cells, and it is unclear how these might affect tumor progression or patient outcomes. METHODS: We combined data from miRNA and messenger RNA (mRNA) expression profiles and bioinformatic analyses to identify an miRNA-mRNA regulatory network in PDAC cell lines (PANC-1 and MIA PaCa-2) and in PDAC samples from patients. We used this information to identify miRNAs that contribute most to tumorigenesis. RESULTS: We identified 3 miRNAs (MIR21, MIR23A, and MIR27A) that acted as cooperative repressors of a network of tumor suppressor genes that included PDCD4, BTG2, and NEDD4L. Inhibition of MIR21, MIR23A, and MIR27A had synergistic effects in reducing proliferation of PDAC cells in culture and growth of xenograft tumors in mice. The level of inhibition was greater than that of inhibition of MIR21 alone. In 91 PDAC samples from patients, high levels of a combination of MIR21, MIR23A, and MIR27A were associated with shorter survival times after surgical resection. CONCLUSIONS: In an integrated data analysis, we identified functional miRNA-mRNA interactions that contribute to growth of PDACs. These findings indicate that miRNAs act together to promote tumor progression; therapeutic strategies might require inhibition of several miRNAs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article